CAS: 1675248-19-7; 3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanamide

英文名称3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanamide
中文名称枸橼酸托法替尼杂质 05
IUPAC名称3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
其它别名Tofacitinib Imp.Q :3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanamide; 3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanamide; Tofacitinib-24; Tofacitinib Citrate Impurity 05; Tofacitinib Related Compound 7; Tofacitinib Impurity Jj; Tofacitinib Impurity 18/3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanamide; Tofacitinib Imp.Q
CAS编号1675248-19-7
MFCD编号:MFCD26967966
FDA UNII编号:PT8DR2MS4E
分子式:C16H22N6O2分子量:330.39
产品CID: 847482
产品分类有机原料 → 有机杂环化合物 → 哌啶类

相似结构搜索
InChIKey: CRDMXSMPTHMXRD-PWSUYJOCSA-N
InChI=1S/C16H22N6O2/c1-10-4-6-22(14(24)7-13(17)23)8-12(10)21(2)16-11-3-5-18-15(11)19-9-20-16/h3,5,9-10,12H,4,6-8H2,1-2H3,(H2,17,23)(H,18,19,20)/t10-,12+/m1/s1
计算化学: 氢键受体数5.0氢键供体数2.0可旋转键数4.0

MSDS等安全信息

警示词warning
危险描述H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
防范说明P264+P280+P305+P351+P338+P337+P313
安全声明H303+H313+H333

上下游产品

tert-butyl (3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carboxylate ethyl malonamate tas°Citinib tas°Citinib

合成工艺路线路线简述

📜3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)哌啶-置于氨体系中,用乙醇用作溶剂,以385 Mg的收率获得托法替尼杂质k
参考文献:托法替布有关物质及其制备方法与应用
标题:托法替布有关物质及其制备方法与应用
摘要:本发明托法替布有关物质及其制备方法与应用,提供了一种新的托法替布杂质式ⅳ化合物及其制备方法,该方法操作简单,产物纯度高,能快速地获取高纯度的托法替布有关物质对照品,有利于托法替布的质量研究,杂质控制,从而提高托法替布的质量控制水平.式ⅳ